These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23386289)

  • 1. Diabetes, renal and cardiovascular disease in p47 phox-/- chronic granulomatous disease.
    Leiding JW; Marciano BE; Zerbe CS; Deravin SS; Malech HL; Holland SM
    J Clin Immunol; 2013 May; 33(4):725-30. PubMed ID: 23386289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis of autosomal recessive chronic granulomatous disease in iran.
    Teimourian S; de Boer M; Roos D
    J Clin Immunol; 2010 Jul; 30(4):587-92. PubMed ID: 20407811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
    Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
    J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly.
    Leusen JH; Meischl C; Eppink MH; Hilarius PM; de Boer M; Weening RS; Ahlin A; Sanders L; Goldblatt D; Skopczynska H; Bernatowska E; Palmblad J; Verhoeven AJ; van Berkel WJ; Roos D
    Blood; 2000 Jan; 95(2):666-73. PubMed ID: 10627478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missense mutations in the gp91-phox gene encoding cytochrome b558 in patients with cytochrome b positive and negative X-linked chronic granulomatous disease.
    Kaneda M; Sakuraba H; Ohtake A; Nishida A; Kiryu C; Kakinuma K
    Blood; 1999 Mar; 93(6):2098-104. PubMed ID: 10068684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.
    Wolach B; Broides A; Zeeli T; Gavrieli R; de Boer M; van Leeuwen K; Levy J; Roos D
    J Clin Immunol; 2011 Aug; 31(4):560-6. PubMed ID: 21604087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of atherosclerosis in chronic granulomatous disease.
    Sibley CT; Estwick T; Zavodni A; Huang CY; Kwan AC; Soule BP; Long Priel DA; Remaley AT; Rudman Spergel AK; Turkbey EB; Kuhns DB; Holland SM; Malech HL; Zarember KA; Bluemke DA; Gallin JI
    Circulation; 2014 Dec; 130(23):2031-9. PubMed ID: 25239440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of patients with p47-phox-deficient chronic granulomatous disease: The significance of recombination events between the p47-phox gene (NCF1) and its highly homologous pseudogenes.
    Vázquez N; Lehrnbecher T; Chen R; Christensen BL; Gallin JI; Malech H; Holland S; Zhu S; Chanock SJ
    Exp Hematol; 2001 Feb; 29(2):234-43. PubMed ID: 11166463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome.
    Falcone EL; Abusleme L; Swamydas M; Lionakis MS; Ding L; Hsu AP; Zelazny AM; Moutsopoulos NM; Kuhns DB; Deming C; Quiñones M; Segre JA; Bryant CE; Holland SM
    Microbiome; 2016 Apr; 4():13. PubMed ID: 27044504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Modalities Based on Flow Cytometry for Chronic Granulomatous Disease: A Multicenter Study in a Well-Defined Cohort.
    Baris HE; Ogulur I; Akcam B; Kiykim A; Karagoz D; Saraymen B; Akgun G; Eltan SB; Aydemir S; Akidagi Z; Bentli E; Nain E; Kasap N; Baser D; Altintas DU; Camcioglu Y; Yesil G; Ozen A; Koker MY; Karakoc-Aydiner E; Baris S
    J Allergy Clin Immunol Pract; 2020; 8(10):3525-3534.e1. PubMed ID: 32736065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of NADPH oxidase in granulocytic cells expressing a delta488-497 gp91(phox) deletion mutant.
    Yu L; Cross AR; Zhen L; Dinauer MC
    Blood; 1999 Oct; 94(7):2497-504. PubMed ID: 10498623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency.
    Ishibashi F; Nunoi H; Endo F; Matsuda I; Kanegasaki S
    Hum Genet; 2000 May; 106(5):473-81. PubMed ID: 10914676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Granulomatous Disease: a Comprehensive Review.
    Yu HH; Yang YH; Chiang BL
    Clin Rev Allergy Immunol; 2021 Oct; 61(2):101-113. PubMed ID: 32524254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematologically important mutations: X-linked chronic granulomatous disease (third update).
    Roos D; Kuhns DB; Maddalena A; Roesler J; Lopez JA; Ariga T; Avcin T; de Boer M; Bustamante J; Condino-Neto A; Di Matteo G; He J; Hill HR; Holland SM; Kannengiesser C; Köker MY; Kondratenko I; van Leeuwen K; Malech HL; Marodi L; Nunoi H; Stasia MJ; Ventura AM; Witwer CT; Wolach B; Gallin JI
    Blood Cells Mol Dis; 2010 Oct; 45(3):246-65. PubMed ID: 20729109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lentiviral gene therapy rescues p47
    Schejtman A; Aragão-Filho WC; Clare S; Zinicola M; Weisser M; Burns SO; Booth C; Gaspar HB; Thomas DC; Condino-Neto A; Thrasher AJ; Santilli G
    Gene Ther; 2020 Sep; 27(9):459-469. PubMed ID: 32533104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of a large cohort of patients with Chronic Granulomatous Disease and identification of novel CYBB mutations: an Italian multicenter study.
    Di Matteo G; Giordani L; Finocchi A; Ventura A; Chiriaco M; Blancato J; Sinibaldi C; Plebani A; Soresina A; Pignata C; Dellepiane RM; Trizzino A; Cossu F; Rondelli R; Rossi P; De Mattia D; Martire B;
    Mol Immunol; 2009 Jun; 46(10):1935-41. PubMed ID: 19410294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.
    Matute JD; Arias AA; Wright NA; Wrobel I; Waterhouse CC; Li XJ; Marchal CC; Stull ND; Lewis DB; Steele M; Kellner JD; Yu W; Meroueh SO; Nauseef WM; Dinauer MC
    Blood; 2009 Oct; 114(15):3309-15. PubMed ID: 19692703
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Kuhns DB; Hsu AP; Sun D; Lau K; Fink D; Griffith P; Huang DW; Priel DAL; Mendez L; Kreuzburg S; Zerbe CS; De Ravin SS; Malech HL; Holland SM; Wu X; Gallin JI
    Blood Adv; 2019 Jan; 3(2):136-147. PubMed ID: 30651282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Chronic Granulomatous Disease in the Kavkazi Population in Israel Reveals Phenotypic Heterogeneity in Patients with the Same NCF1 mutation (c.579G>A).
    Wolach B; Gavrieli R; de Boer M; van Leeuwen K; Wolach O; Grisaru-Soen G; Broides A; Etzioni A; Somech R; Roos D
    J Clin Immunol; 2018 Feb; 38(2):193-203. PubMed ID: 29411231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.